sellWeak cluster of 410b5-1 plan
Kavita Patel sold $99k of ACLX
director at Arcellx, Inc.. 1,500 shares at an average of $65.87, traded Jan 14, 2025, filed Jan 14, 2025.
Warning score
25Value
$99k
1,500 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +10Trade size$99k at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-001452, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 14, 2025 | MOption exercise Common Stock10b5-1 | +1,500 | $6.66 | $9,990 | 1,500 | Jan 14, 2025 |
| Jan 14, 2025 | SOpen-market sale Common Stock10b5-1 | -800 | $64.95 | $52k | 700 | Jan 14, 2025 |
| Jan 14, 2025 | SOpen-market sale Common Stock10b5-1 | -400 | $66.62 | $27k | 300 | Jan 14, 2025 |
| Jan 14, 2025 | SOpen-market sale Common Stock10b5-1 | -300 | $67.32 | $20k | 0 | Jan 14, 2025 |
| Jan 14, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,500 | $0.00 | $0 | 37,577 | Jan 14, 2025 |
Related signals
Other insiders at Arcellx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $31k 340 shares | -54% | |
| 30Weak | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $488k 5,364 shares | -39% | |
| 38Weak | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $512k 5,946 shares | -30% | |
| 48Moderate | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $1.7M 21,034 shares | -97% | |
| 3Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $5,852 73 shares | -0% | |
| 38Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $993k 12,396 shares | -36% | |
| 9Weak | Arcellx, Inc. | Christopher Heery CHIEF MEDICAL OFFICER | $291k 3,643 shares | -10% | |
| 18Weak | Arcellx, Inc. | Kavita Patel director | $101k 1,500 shares | -100% | |
| 47Moderate | Arcellx, Inc. | Michelle Gilson CHIEF FINANCIAL OFFICER | $785k 12,235 shares | -38% | |
| 17Weak | Arcellx, Inc. | Kavita Patel director | $88k 1,500 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.